Sanofi said it would halt development of its vaccine against Covid-19 based on mRNA technology despite it having showed positive early-stage trial results.
賽諾菲(Sanofi)表示將停止對基於mRNA技術的新冠疫苗的研發，儘管該公司已經在早期試驗中取得了積極成果。
您已閱讀10%（210字），剩餘90%（1802字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。